A large scale prediction of bacteriocin gene blocks suggests a wide functional spectrum for bacteriocins

BMC Bioinformatics

Volumn 16, Issue 1, 2015, Pages

  Morton, James T ^a,d   Freed, Stefan D ^b   Lee, Shaun W ^b   Friedberg, Iddo ^a,c  

^a MIAMI UNIVERSITY   (United States)

^b UNIVERSITY OF NOTRE DAME   (United States)

^c IOWA STATE UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bacteriocins; Gene blocks; Microbiology; Operons

Indexed keywords

AVAILABILITY; BACTERIA; BIOCHEMISTRY; HIDDEN MARKOV MODELS; MARKOV PROCESSES; MICROBIOLOGY; MOLECULES;

BACTERIOCINS; ENZYMATIC MODIFICATION; LARGE-SCALE PREDICTION; OPERONS; POST-TRANSLATIONAL PROCESSING; PROFILE HIDDEN MARKOV MODEL; SOFTWARE AVAILABILITY; STRUCTURAL DIVERSITY;

GENES;

ANTIINFECTIVE AGENT; BACTERIOCIN;

ANTAGONISTS AND INHIBITORS; ARCHAEAL GENOME; BACTERIAL GENOME; CHROMOSOMAL MAPPING; GENETICS; METABOLISM; OPERON; SOFTWARE;

ANTI-BACTERIAL AGENTS; BACTERIOCINS; CHROMOSOME MAPPING; GENOME, ARCHAEAL; GENOME, BACTERIAL; OPERON; SOFTWARE;

EID: 84947867929     PISSN: None     EISSN: 14712105     Source Type: Journal    
DOI: 10.1186/s12859-015-0792-9     Document Type: Article

References (35)

1. Farnsworth NR, Akerele O, Bingel AS, Soejarto DD, Guo Z. Medicinal plants in therapy. Bull World Health Organ. 1985; 63:965-81.
2. AL H. Natural products in drug discovery. Drug Discov Today. 2008; Oct;13(19-20):894-901.
3. Li JW-HW, Vederas JC. Drug discovery and natural products: end of an era or an endless frontier?Sci (New York, NY). 2009; 325(5937):161-5. doi: 10.1126/science.1168243.
4. Willey JM, van der Donk WA. Lantibiotics: peptides of diverse structure and function. Ann Rev Microbiol. 2007; 61:477-501.
5. Guder A, Wiedemann I, Sahl HG. Posttranslationally modified bacteriocins-the lantibiotics. Biopolymers. 2000; 55(1):62-73. doi: 10.1002/1097-0282.
6. Arnison PG, Bibb MJ, Bierbaum G, Bowers AA, Bugni TS, Bulaj G, et al. Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature. Nat Prod Rep. 2013; 30(1):108-60. doi: 10.1039/c2np20085f.
7. Perez RH, Zendo T, Sonomoto K. Novel bacteriocins from lactic acid bacteria (LAB): various structures and applications. Microb Cell Fact. 2014 Suppl1:S3.
8. van Heel AJ, de Jong A, Montalbán-López M, Kok J, Kuipers OP. Bagel3: automated identification of genes encoding bacteriocins and (non-)bactericidal posttranslationally modified peptides. Nucleic Acids Res. 2013; 41(W1):448-53. doi: 10.1093/nar/gkt391.
9. Hammami R, Zouhir A, Hamida JB, Fliss I. Bactibase: a new web-accessible database for bacteriocin characterization. BMC Microbiol. 2007; 7(1):89. doi: 10.1186/1471-2180-7-89.
10. Blin K, Medema MH, Kazempour D, Fischbach MA, Breitling R, Takano E, et al. antismash 2.0-a versatile platform for genome mining of secondary metabolite producers. Nucleic Acids Res. 2013; 41(W1):204-12. doi: 10.1093/nar/gkt449.
11. Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z, Miller W, et al. Gapped blast and psi-blast: a new generation of protein database search programs. Nucleic Acids Res. 1997; 25(17):3389-402. doi: 10.1093/nar/25.17.3389.
12. Lee SW, Mitchell DA, Markley AL, Hensler ME, Gonzalez D, Wohlrab A, et al. Discovery of a widely distributed toxin biosynthetic gene cluster. Proc Nat Acad Sci. 2008; 105(15):5879-84. doi: 10.1073/pnas.0801338105.
13. Benson DA, Clark K, Karsch-Mizrachi I, Lipman DJ, Ostell J, Sayers EW. Genbank. Nucleic Acids Res. 2014; 42(D1):32-7. doi: 10.1093/nar/gkt1030.
14. Coburn PS, Gilmore MS. The enterococcus faecalis cytolysin: a novel toxin active against eukaryotic and prokaryotic cells. Cell Microbiol. 2003; 5(10):661-9.
15. Gálvez A, Maqueda M, Martínez-Bueno M, Valdivia E. Bactericidal and bacteriolytic action of peptide antibiotic as-48 against gram-positive and gram-negative bacteria and other organisms. Res Microbiol. 1989; 140(1):57-68.
16. Salomón RA, Farías RN. Microcin 25, a novel antimicrobial peptide produced by escherichia coli. J Bacteriol. 1992; 174(22):7428-35.
17. Kaletta C, Entian KD. Nisin, a peptide antibiotic: cloning and sequencing of the nisa gene and posttranslational processing of its peptide product. J Bacteriol. 1989; 171(3):1597-601.
18. Nizet V, Beall B, Bast DJ, Datta V, Kilburn L, Low DE, et al. Genetic locus for streptolysin s production by group a streptococcus. Infect Immun. 2000; 68(7):4245-54.
19. Ross KF, Ronson CW, Tagg JR. Isolation and characterization of the lantibiotic salivaricin a and its structural gene sala from streptococcus salivarius 20p3. Appl Environ Microbiol. 1993; 59(7):2014-21.
20. Shoji J, Hinoo H, Wakisaka Y, Koizumi K, Mayama M. Isolation of three new antibiotics, thiocillins i, ii and iii, related to micrococcin p. studies on antibiotics from the genus bacillus. viii. J Antibiot. 1976; 29(4):366-74.
21. Li W, Godzik A. Cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences. Bioinformatics (Oxford, England). 2006; 22(13):1658-9. doi: 10.1093/bioinformatics/btl158.
22. Katoh K, Standley DM. Mafft multiple sequence alignment software version 7: improvements in performance and usability. Mol Biol Evol. 2013; 30(4):772-80. doi: 10.1093/molbev/mst010.
23. Eddy SR. Accelerated profile hmm searches. PLoS Comput Biol. 2011; 7(10):1002195. doi: 10.1371/journal.pcbi.1002195.
24. Dimov SHN, Ivanova P. Genetics of bacteriocins biosynthesis by lactic acid bacteria. Biotechnol Biotechnol Equip. 2005; 19(supplement 2):4-10.
25. Minces LR, Brown PJ, Veldkamp PJ. Human meningitis from streptococcus equi subsp. zooepidemicus acquired as zoonoses. Epidemiol Infect. 2011; 139(3):406-10.
26. Ohnishi Y, Ishikawa J, Hara H, Suzuki H, Ikenoya M, Ikeda H, et al. Genome sequence of the streptomycin-producing microorganism streptomyces griseus ifo 13350. J Bacteriol. 2008; 190(11):4050-60. doi: 10.1128/jb.00204-08.
27. Ghai M, Singh V, Martin LA, McFarlane SA, van Antwerpen T, Rutherford RS. A rapid and visual loop-mediated isothermal amplification assay to detect leifsonia xyli subsp. xyli targeting a transposase gene. Lett Appl Microbiol. 2014; 59(6):648-57.
28. Donia MS, Schmidt EW. Linking chemistry and genetics in the growing cyanobactin natural products family. Chem Biol. 2011; 18(4):508-19.
29. Tabata A, Nakano K, Ohkura K, Tomoyasu T, Kikuchi K, Whiley RA, et al. Novel twin streptolysin s-like peptides encoded in the sag operon homologue of beta-hemolytic streptococcus anginosus. J Bacteriol. 2013; 195(5):1090-9.
30. Houssen WE, Koehnke J, Zollman D, Vendome J, Raab A, Smith MC, et al. The discovery of new cyanobactins from cyanothece pcc 7425 defines a new signature for processing of patellamides. Chembiochem: Eur J Chem Biol. 2012; 13(18):2683-9.
31. Mitchell DA, Lee SW, Pence MA, Markley AL, Limm JD, Nizet V, et al. Structural and functional dissection of the heterocyclic peptide cytotoxin streptolysin s. J Biol Chem. 2009; 284(19):13004-12.
32. Haft DH, Basu MKK, Mitchell DA. Expansion of ribosomally produced natural products: a nitrile hydratase- and Nif11-related precursor family. BMC Biology. 2010; 8:70.
33. Sardar D, Pierce E, McIntosh JA, Schmidt EW. Recognition sequences and substrate evolution in cyanobactin biosynthesis. ACS Synth Biol. 2015; 4(2):167-76. doi: 10.1021/sb500019b.
34. Karaya K, Shimizu T, Taketo A. New gene cluster for lantibiotic streptin possibly involved in streptolysin s formation. J Biochem. 2001; 129(5):769-75.
35. Wescombe PA, Tagg JR. Purification and characterization of streptin, a type a1 lantibiotic produced by streptococcus pyogenes. Appl Environ Microbiol. 2003; 69(5):2737-47. doi: 10.1128/aem.69.5.2737-2747.2003.